Litigation Details for Sanofi-Aventis U.S. LLC v. Actavis LLC (D. Del. 2020)
✉ Email this page to a colleague
Sanofi-Aventis U.S. LLC v. Actavis LLC (D. Del. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-06-12 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 10,583,110; 8,927,592 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Sanofi-Aventis U.S. LLC v. Actavis LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Sanofi-Aventis U.S. LLC v. Actavis LLC (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-09-09 | 107 | Claim Construction Chart | Chart for U.S. Patent Nos. 10,583,110 (“the ’110 patent”) and 10,716,777 (“the ’777 patent”). The…the ’110 patent. Exhibit B to the Joint Claim Construction Chart is a copy of the ’777 patent. Exhibit… ’110 Patent, Figs. 1-5 ’777 patent, Exhibit B, including…110 Patent at 2:43-3:41 Prosecution file history of the ’110 patent, … Prosecution file history of the ’777 patent, ’110 Patent at 8:61-65 Exhibit D | External link to document |
| 2021-01-04 | 209 | Opinion - Memorandum Opinion | U.S. Patent No. 10,583,110 (“the ‘110 Patent”) and U.S. Patent No. 10,716,777 (“the ‘777 Patent”). The…OPINION providing claim construction for U.S. Patent Nos. 10,583,110 and 10,716,777. Within five days the parties… defined in the ‘110 and ‘777 Patents. ‘110 Patent 11:20-22; ‘777 Patent 11:19-20. This understanding …administration of said cabazitaxel.” ‘110 Patent 18:8-18. Claim 1 of the ‘777 Patent discloses a method using a “dose…cabazitaxel.” ‘777 Patent 18: 54- 61. 1 1 Why the ‘777 Patent, which is a continuation | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
